Literature DB >> 6421396

Paranoid psychosis induced by tocainide.

P Currie, D R Ramsdale.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6421396      PMCID: PMC1444327          DOI: 10.1136/bmj.288.6417.606

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  4 in total

1.  Efficacy of a new oral agent (tocainide) in the acute treatment of refractory ventricular arrhythmias.

Authors:  W Ryan; R Engler; M LeWinter; J S Karliner
Journal:  Am J Cardiol       Date:  1979-02       Impact factor: 2.778

2.  Severe paranoia with concomitant tocainide and propranolol therapy.

Authors:  M Rubino; E Jackson
Journal:  Clin Pharm       Date:  1982 Mar-Apr

3.  Lidocaine and psychotic reactions.

Authors:  W M Turner
Journal:  Ann Intern Med       Date:  1982-07       Impact factor: 25.391

4.  Long-term tocainide therapy for ventricular arrhythmias.

Authors:  R A Winkle; P J Meffin; D C Harrison
Journal:  Circulation       Date:  1978-05       Impact factor: 29.690

  4 in total
  4 in total

1.  Dysarthria and visual hallucinations due to flecainide toxicity.

Authors:  E Ramhamadany; S Mackenzie; D R Ramsdale
Journal:  Postgrad Med J       Date:  1986-01       Impact factor: 2.401

Review 2.  Adverse effects of class I antiarrhythmic drugs.

Authors:  J Caron; C Libersa
Journal:  Drug Saf       Date:  1997-07       Impact factor: 5.606

Review 3.  Drug-induced psychiatric disorders and their management.

Authors:  L E Hollister
Journal:  Med Toxicol       Date:  1986 Nov-Dec

Review 4.  Neurologic complications of cardiovascular diseases.

Authors:  W R Slade; A C McNeal; P S Tse
Journal:  J Natl Med Assoc       Date:  1989-02       Impact factor: 1.798

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.